Supported by the Institut Catholique de Lille, GHICL is a private non-profit university hospital group that manages 686 beds in two establishments, with comprehensive care services including emergency, surgery, pharmacy, adult psychiatry , obstetrics, pediatrics, rehabilitation and units such as laboratories and surgeries.
The Saint-Brieuc Hospital Center is today the first reference center in health region no. 7 in Brittany, providing specialized care for the entire Côtes d’Armor department. With 1,238 beds, it serves a population of approximately 100,000 inhabitants.
The Argenteuil Hospital Center also plays a key role as a local hospital with a living area of nearly 300,000 inhabitants, with nearly 2,300 healthcare professionals based in Paris.
Resah is a public interest group (GIP) whose objective is to support the pooling and professionalization of purchases from the health sector, public and private not-for-profit. It was created in 2007 to support the pooling of hospital purchases in the Ile-de-France region, in collaboration with Achat Hopital.
UniHA, the Union of Hospitals for Purchases, is a cooperative of buyers of French public hospitals. Created in 2005 by the hospital staff themselves (32 CHU and 20 CH), today in 2020, 955 hospitals have joined the cooperative, 102 GHT and will have achieved 4.6 billion euros in group purchases in 2019.
Deenova is the undisputed leading provider of combined mechatronic solutions (robotics and automation) for closed-loop drug and medical device traceability in the healthcare industry anytime, anywhere. Deenova’s unique and fully integrated solutions have been and will go a long way to alleviating the increasing pressures from healthcare providers to: simultaneously improve patient safety, reduce processing errors, minimize waste and diversion of controlled substances, contain costs and reduce the gap between increased volume / acuity of patients and scarce medical personnel. Deenova guarantees the simplification of all processes related to the management of drugs and implantable / disposable medical devices with expected cost savings of between 15% and 25%.
Please visit www.deenova.com for more information.